TITLE

Asenapine Sublingual Tablets (Saphris®)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
October 2009
SOURCE
Internal Medicine Alert;10/29/2009, Vol. 31 Issue 20, p157
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers updates on the approval of the sublingual tablet Asenapine by the U.S. Food and Drug Administration and marketed by the Schering-Plough Corp. for treating an acute schizophrenia, manic, or mixed episodes linked with bipolar disease in adults with minimal weight gain advantage.
ACCESSION #
44960624

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics